Skip to main content
Sister Publication Links
  • Rubber & Plastics News
Subscribe
  • My Account
  • LogIn
  • News
  • Technology Focus
    • Features
    • Technical Papers
    • Analysis: Rubber mixing plants of the future
      Analysis: US probes dumping by ESBR suppliers
      Opinion: Tire labels stuck in a rut
      Analysis: NR pricing takes one step forward, two steps back
    • White paper: Role of tire innerliners in improving 'in-use rolling resistance'
      White paper: Why tire air retention matters now more than ever
      Nippon Soda: Use of 1,2-polybutadiene in CSM rubber applications
      Elastomers for Sustainability Top 10
  • Events
    • ERJ Events
    • ERJ Livestreams & Webinars
    • Industry Events
    • Journey to Automation Awards 2020
      Sustainability: Top 10 E4S projects table
  • Maps & Reports
  • People
  • Directory
  • Digital Edition
  • Brainiac
MENU
Breadcrumb
  1. Home
  2. News
December 15, 2017 12:00 AM

Datwyler to start Indian production unit mid-2018

Shahrzad Pourriahi
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print

    Pune, India – Datwyler Sealing Solutions is preparing to start production of pharmaceutical rubber components at a new facility on its Satara site in Pune.

    Product manufacture is scheduled to start in the second quarter of 2018 and samples to reach customers by the yearend.

    In correspondence with ERJ, Datwyler said the investment – the amount was not disclosed – was intended to strengthen its position in the Indian pharma and healthcare market.

    The project will increase manufacturing volume at the site to five billion components per year, and more than double its production area to 58,000 sq. feet.

    The Swiss company is currently producing close to four billion components for vials, pre-filled syringes, and diagnostic devices at Satara.

    The site operates to Datwyler’s ‘first line’ standard, based on advanced cleanroom technology, automated production, camera inspection and special cleaning processes.

    The new unit is specially designed to manufacture pharmaceutical rubber components in a fully integrated GMP environment.

    As part of Datwyler Sealing Solutions, the original plant has been delivering commercial supplies to customers worldwide since 2010.

    The new facility will produce complex rubber vial and syringe components, for the company’s Omni Flex product range.

    “These complex products have a total fluoropolymer coating which prevents any interaction with the drugs,” Rahul Dev, Datwyler’s India VP previously told ERJ.

    In addition to Omni Flex, the Pune site will also be focusing on “high-end rubber formulations” for products such as plunger stoppers, serum stoppers and customised stoppers.

    The Indian market, said Datwyler, has become “increasingly important” for global pharma manufacturers in recent years.

    The country, it added, is rapidly becoming “one of the most important global manufacturing destinations, particularly in generics and biotech.”

    RECOMMENDED FOR YOU
    German rubber industry to return to double-digit growth in 2021
    German rubber industry to return to double-digit growth in 2021
    Yokohama rings the changes with YX2023
    Yokohama rings the changes with YX2023
    Synthomer dismisses takeover reports
    Synthomer dismisses takeover reports
    Free Newsletters

    Breaking news and in-depth coverage of essential topics delivered straight to your inbox.

    Subscribe today

    Get the latest news impacting the European rubber industry, from breaking news to razor-sharp analysis, in print and online.

    Subscribe now
    Connect with Us
    • LinkedIn
    • Twitter
    • Youtube

    Logo
    Contact Us

    @ 2019 European Rubber Journal. 
    European Rubber Journal is published bi-monthly by NUERJ Ltd.

    Registered Office: Castle House, 89 High Street,
    Berkhamsted, Hertfordshire HP4 2DF, United Kingdom. 

    Tel. + 44 (0)203 196 0141 

    Registered No. 13104613 England

    Email: [email protected]

    Website www.european-rubber-journal.com

    Customer service 

    Tel. + 44 (0)203 196 0141 

     

    Resources
    • About us
    • Contact Us
    • Advertise with Us
    • Media Kit
    • Ad Choices Ad Choices
    • Sitemap
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Copyright © 1996-2021. Crain Communications, Inc. All Rights Reserved.
    • News
    • Technology Focus
      • Features
      • Technical Papers
    • Events
      • ERJ Events
      • ERJ Livestreams & Webinars
      • Industry Events
    • Maps & Reports
    • People
    • Directory
    • Digital Edition
    • Brainiac